Disruption of Th17/Treg balance in the sputum of patients with chronic obstructive pulmonary disease

American Journal of the Medical Sciences

Volumn 349, Issue 5, 2015, Pages 392-397

  Li, Haijun ^a,b   Liu, Qixiao ^a   Jiang, Yuanyuan ^a   Zhang, Yi ^a   Zhang, Yan ^a   Xiao, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

^b Physical Examination Office Health Department of Shandong Province   (China)

Author keywords

COPD; Inflammation; Molecular biology; Respiratory function tests; Tobacco

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; PROTEIN; RECEPTOR RELATED ORPHAN RECEPTOR 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; ORPHAN NUCLEAR RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CELLULAR PARAMETERS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; HUMAN; LYMPHOCYTE DIFFERENTIATION; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPUTUM ANALYSIS; SPUTUM LEVEL; TH17 CELL; TH17 TREG BALANCE; AGED; INFLAMMATION; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY SYSTEM; SMOKING; SPUTUM;

AGED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-17; MALE; MIDDLE AGED; ORPHAN NUCLEAR RECEPTORS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM; SMOKING; SPUTUM; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84928945865     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000447     Document Type: Article

References (32)

1. Tan WC, Seale P, Ip M, et al. Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific. Respirology 2009;14: 90-7.
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
3. Roth M. Pathogenesis of COPD. Part III. Inflammation in COPD. Int J Tuberc Lung Dis 2008;12:375-80.
4. Alcorn JF, Crowe CR, Kolls JK. TH17 cells in asthma and COPD. Annu Rev Physiol 2010;72:495-516.
5. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-80.
6. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-32.
7. Unutmaz D. RORC2: the master of human Th17 cell programming. Eur J Immunol 2009;39:1452-5.
8. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009;361:888-98.
9. Schubert LA, Jeffery E, Zhang Y, et al. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001;276:37672-9.
10. Kondelkova K, Vokurkova D, Krejsek J, et al. Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Med (Hradec Kralove) 2010;53:73-7.
11. Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007;19:409-17.
12. Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 2005;102:5138-43.
13. Torgerson TR, Genin A, Chen C, et al. FOXP3 inhibits activationinduced NFAT2 expression in T cells thereby limiting effector cytokine expression. J Immunol 2009;183:907-15.
14. Xing Q, Wang B, Su H, et al. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis. Rheumatol Int 2012;32:949-58.
15. Wang W, Shao S, Jiao Z, et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int 2012;32:887-93.
16. Li J, Wang L, Wang S, et al. The Treg/Th17 imbalance in patients with idiopathic dilated cardiomyopathy. Scand J Immunol 2010;71: 298-303.
17. Barcelo B, Pons J, Ferrer JM, et al. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 2008;31: 555-62.
18. Vargas-Rojas MI, Ramirez-Venegas A, Limon-Camacho L, et al. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir Med 2011;105:1648-54.
19. Wang H, Peng W, Weng Y, et al. Imbalance of Th17/Treg cells in mice with chronic cigarette smoke exposure. Int Immunopharmacol 2012;14:504-12.
20. Vestbo AAJ, Anzueto A, Barnes P, et al. Global Initiative for Chronic Obstructive Lung Disease; 2009. Available from http://www.goldcopd.org/. Accessed March 2, 2015.
21. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-9.
22. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colonystimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001;194:519-27.
23. Chen Y, Thai P, Zhao YH, et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 2003;278:17036-43.
24. Fujisawa T, Velichko S, Thai P, et al. Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm. J Immunol 2009;183:6236-43.
25. Kim CH. Migration and function of Th17 cells. Inflamm Allergy Drug Targets 2009;8:221-8.
26. Isajevs S, Taivans I, Strazda G, et al. Decreased FOXP3 expression in small airways of smokers with COPD. Eur Respir J 2009;33:61-7.
27. Plumb J, Smyth LJ, Adams HR, et al. Increased T-regulatory cells within lymphocyte follicles in moderate COPD. Eur Respir J 2009;34: 89-94.
28. Roos-Engstrand E, Pourazar J, Behndig AF, et al. Expansion of CD4+CD25+ helper T cells without regulatory function in smoking and COPD. Respir Res 2011;12:74.
29. Zhou L, Ivanov II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8:967-74.
30. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009;30:646-55.
31. Jiang YY, Xiao W, Zhu MX, et al. The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease. Respir Med 2012;106:1680-9.
32. Mader JS, Ewen C, Hancock RE, et al. The human cathelicidin, LL- 37, induces granzyme-mediated apoptosis in regulatory T cells. J Immunother 2011;34:229-35.